Phase I trial of ZD1694, a new folate-based thymidylate synthase inhibitor, in patients with solid tumors.
Clarke SJ, Hanwell J, de Boer M, Planting A, Verweij J, Walker M, Smith R, Jackman AL, Hughes LR, Harrap KR, Kennealey GT, Judson IR.
Clarke SJ, et al. Among authors: kennealey gt.
J Clin Oncol. 1996 May;14(5):1495-503. doi: 10.1200/JCO.1996.14.5.1495.
J Clin Oncol. 1996.
PMID: 8622063
Clinical Trial.